Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT03602742
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Sigknow Biomedical Co., Ltd.
- Registry
-
NCT03602742
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT03602742. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-03-16 (actual); primary completion 2018-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO
- Condition
- Atrial Fibrillation
- Condition
- Arrhythmias, Cardiac
- Intervention (Device)
- EZYPRO®
- Lead sponsor
- Sigknow Biomedical Co., Ltd.
Record details
- Record id
cardio:ct-nct03602742- Content hash
a704662dec18029dc851c1536ccda922a081bf9f92e9de0a2b07e438d52f4164